Technology
Electronic Caregiver launches first living avatar for care at home
Addison connects the patient with primary care, emergency response, friends and family.

US health technology company, Electronic Caregiver, has launched its first 3D living avatar for care management.
Through voice and touch interaction, Addison, the 3D-animated Virtual Caregiver helps monitor the health of ageing and chronically ill clients at home.
Addison is an all-in-one Telecare solution, connecting the patient with primary care, emergency response, friends, and family.
As the next generation of virtual voice assistant, Addison reminds users to take prescribed medications, conducts interactive health assessments, delivers dosing compliance verification to caregivers and providers, and assists patients in recording vital sign measurements to monitor specific conditions.
The Addison Care system can be paired with various Bluetooth devices, such as a glucometer for patients with diabetes or a weight scale and blood pressure cuff for patients who have or are managing heart disease.
Addison tracks medication adherence and vital sign trends over time, allowing clients, their caregivers, and providers to catch any escalations before they become problematic.
Users can tell Addison to call emergency services if they fall and can’t reach the phone, or to call their daughter to remind her to pick them up for an appointment in the morning. Should their vitals show signs of health decline, Addison will inform their caregiver and doctor. The Virtual Caregiver also offers telehealth services and Care Coaching.
Addison Care devices can also be implemented in senior living communities and health care organisations, providing health and security services to a large number of people.
Addison has been a dream of Electronic Caregiver’s founder and CEO Anthony Dohrmann since the company was founded in 2009.
“Addison is the most transformational and engaging interface for human interaction with technology ever created,” Dohrmann said.
“For years consumers have wondered what Siri and Alexa might look like behind the voice. Addison adds far more than a mere face and body to the voice. Addison provides a dynamic, ever-changing, emotionally stimulating, personalised experience to the user. Addison can educate, demonstrate, inquire, and connect.”
The launch of Addison comes at a pivotal time. The US Census Bureau has reported that by 2034, older adults will outnumber children. This will leave fewer family members to help care for ageing loved ones. Already, 39.8 million people are providing informal care for the elderly and chronically ill with more than 20 percent of caregivers’ own health declining.
In addition, the cost of assisted living continues to skyrocket. According to research published by the National Institutes of Health in 2021, the median cost of assisted living is $4,300 per month. Unpaid family caregivers are also hit with a high financial burden, spending an average of 26 percent of their income on caregiving activities, according to the AARP.
The living avatar talks to and reacts to clients, mirrors time of day, weather, holiday celebrations, and faith. Users can personalise environments, gender, ethnicity, decor, locations, fonts, tones, coloUrs, apparel, and language. They can interact with objects, animals, musical instruments, media, and characters in Addison’s world.
“You know [Addison’s] not human, but it’s nice to have a person there, and it’s fun to watch her,” said Coralee Armstrong, 82, an Addison Care client living in Greenville, Pa.
“It’s kind of like an extra person in the house. It’s kind of like company.”
The company says that Addison will soon incorporate physical and mental health routines and video televisits with healthcare professionals.
The living avatar will offer third party service integrations for grocery delivery, rideshare, and connected home solutions. Additionally, clinical Addison configurations are being created for bedside patient management in hospitals, including intake and discharge processes.
News
SimpleC launches AI companion for dementia carers

SimpleC has launched Wellby, an AI companion for unpaid dementia carers, offering round-the-clock emotional support and practical guidance.
Announced at CES in Las Vegas, Wellby is designed for caregivers of people with Alzheimer’s disease and related dementias.
Some 63 million people in the US provide unpaid care to older adults, including 12 million specifically caring for those with dementia. SimpleC says many face emotional strain, uncertainty and limited timely guidance.
Unlike general-purpose AI tools, Wellby is built for caregiving support, delivering personalised, real-time assistance through natural conversation.
Kevin Henze, chief executive of SimpleC, said: “This launch reinforces our belief that technology should support caregivers with both intelligence and compassion.
“As a privately owned, mission-driven company, we’re able to prioritise affordability, accessibility, and long-term caregiver impact. Wellby represents technology with soul—AI designed to truly walk alongside caregivers.”
Future releases will integrate the companion into SimpleC’s Connected Care Platform and extend it to serve older adults ageing in place.
Jun Ying, chief product officer, said: “By integrating AI across our platform, we’re creating a connected ecosystem where caregivers and care recipients can access multiple services—support, monitoring, guidance, and coordination—through a single, trusted SimpleC experience.”
Technology
Billionaire Platt backs Engitix again with US$25m

London-based biotech Engitix has raised US$25m in a Series A extension, with billionaire hedge fund founder Mike Platt backing the company for the second time.
The preclinical company is developing therapies that target the extracellular matrix (ECM), the structural material surrounding cells in tissues, in solid tumours and fibrosis.
Founder Giuseppe Mazza said the company chose to present the funding as an extension rather than a new round to match its current stage.
“We are still preclinical and want the financing label to match the company’s current stage; the series B is intended to be the step-up round once we are ready to enter the clinic and pursue clinical proof-of-concept, which typically supports a larger raise,” he said.
The extension was led by Netherton Investments, which invests on behalf of Platt, co-founder of BlueCrest Capital Management. Platt also co-led the company’s US$54m Series A in 2022.
Mazza said: “We target disease-specific changes in the extracellular matrix, which is the abnormal tissue environment that actively drives both cancer and fibrosis. In oncology, patients with desmoplastic tumours have particularly poor outcomes because the dense tumour matrix limits the effectiveness of current treatments.
“By targeting disease-specific ECM changes, we can anchor therapies directly to tumour tissue in hard-to-treat, desmoplastic cancers and aim to actively clear established scar tissue in fibrosis.”
Engitix has three disclosed preclinical programmes and two confidential collaborative programmes with Takeda.
News
Thymus regeneration firm TECregen raises CHF 10m
News4 weeks agoCommonly-prescribed drugs liked to 50% increased risk of dementia
Wellness4 weeks agoVaccine raises hope for million living with knee osteoarthritis
Insights4 weeks agoStudy reveals habits that could lower brain age by eight years
News4 weeks agoLoss of confidence in midlife linked to dementia
News4 weeks agoConcurrent frailty and depression likely boost dementia risk in older people, study finds
News4 weeks agoSanofi and ADEL sign US$1.04bn Alzheimer’s deal
News4 weeks agoYellow wristbands launched to help locate people with dementia
Research4 weeks agoSitting by window improves blood sugar control in diabetes patients – study





















